Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000006734
JPRN-UMIN000006734
Completed
未知

Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer - Focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancer

Department of Radiation Oncology,Kawasaki Medical School0 sites10 target enrollmentDecember 1, 2011
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionslocal relapse case with prostate cancer after radiotherapy

Overview

Phase
未知
Intervention
Not specified
Conditions
local relapse case with prostate cancer after radiotherapy
Sponsor
Department of Radiation Oncology,Kawasaki Medical School
Enrollment
10
Status
Completed
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 1, 2011
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Male

Investigators

Sponsor
Department of Radiation Oncology,Kawasaki Medical School

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •patients with double cancers patients with hormon refractry patients with unsuitable factors to carry out this salvage HDR\-BT

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Phase one/two study of focal salvage high-dose-rate brachytherapy for patient with PSA-failure after radiotherapy for prostate cancerRecurrent prostate cancer after radiotherapy
JPRN-UMIN000013140Kawasaki Medical School30
Completed
Phase 1
Clinical trial to evaluate safety, tolerability and pharmacokinetic of herbal (ICB-014-A002) capsule in healthy adult volunteers.
CTRI/2018/01/011259Indian Institute of Integrative Medicine Council of Scientific Industrial Research38
Active, not recruiting
Phase 1
A clinical gene therapy study with hematopoietic stem cells for the treatment of patients suffering from a plasma cell tumor.Multiple myeloma in early relapse after intensive front line therapyMedDRA version: 20.0Level: LLTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 100000004864Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
EUCTR2018-001741-14-ITOSPEDALE SAN RAFFAELE3
Completed
Not Applicable
A PHASE I/II DOSE-FINDING STUDY OF HIGH-DOSE FLUCONAZOLE TREATMENT IN AIDS-ASSOCIATED CRYPTOCOCCAL MENINGITIS-B24 Unspecified human immunodeficiency virus [HIV] diseaseUnspecified human immunodeficiency virus [HIV] diseaseB24
PER-030-10INSTITUTO NACIONAL DE ALERGIAS Y ENFERMEDADES INFECCIOSAS DE LOS ESTADOS UNIDOS, SOCIAL & SCIENTIFIC SYSTEMS, INC,,
Active, not recruiting
Not Applicable
A prospective phase II study on dose escalation using PET based adaptive IMRT stage II-III non small lung cancerStage II-III Non small lung cancerTherapeutic area: Diseases [C] - Cancer [C04]
EUCTR2011-003124-12-BECliniques Universitaires Saint Luc